Oscient Pharmaceuticals Corporation Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 7 Calls Today's Calls

Call Details Oscient Pharmaceuticals Corporation Earnings Conference Call (Q1 2008) Wed, May 7, 2008, 8:30 am Eastern Listen to the archived event audio About Oscient Pharmaceuticals Corporation (NasdaqGM:OSCI) Oscient Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, sells and markets products to community-based primary care physicians through its primary care sales force in the United States. The company markets ANTARA (fenofibrate) capsules, a cardiovascular product used for the treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet; and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic used for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate severity. It also has a novel, late-stage antibiotic candidate, Ramoplanin, for the treatment of clostridium difficile-associated disease. Oscient Pharmaceuticals was founded in 1961 as Genome Therapeutics and changed its name in 2004. The company is headquartered in Waltham, Massachusetts. More Info: Quote | Chart | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings